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Purpose: Magnetic resonance arteriography (MRA) of  the lower extremities affords several 
possible advantages over conventional contrast arteriography (CA). We hypothesized 
that MRA of  the infrageniculate vessels was sufficiently accurate to replace CA before 
revascularization procedures in patients with limb-threatening ischemia. 
Methods: Fifty-three extremities in 49 patients were prospectively evaluated b fore at- 
tempted infrageniculate r vascularization procedures with preoperative infrageniculate 
time-of-flight MRA (cost, $170/study) and standard contrast arteriography (cost, 
$1310/study) of  the aortoiliac and runoff vessels. Independent operative plans were 
formulated based on the MRA and CA results before the revascularization procedure. 
Intraoperative, prebypass arteriograms (IOA; cost, $46/study) were obtained in all 
patients to confirm the adequacy of  the distal runoff. The preoperative plans formulated 
by the results of  MRA and CA were compared with the actual procedure performed based 
on the IOA. All arteriograms (CA, MRA, IOA) were reviewed after the operation by two 
independent reviewers, and the number of  patent vessel segments and those with < 50% 
stenosis was determined. 
Results: Revascularization procedures were performed in 44 of  53 extremities (83%), and 
amputation was performed in nine extremities (17%) because of an absence of  a suitable 
bypass target. The CA and MRA were equally effective in predicting the optimal operative 
plans as determined from IOA (CA, 42 of  53 [77%] vs MRA, 40 of  53 [75%]; p = 0.79). 
More patent vessel segments were s en on CA than MRA (reviewer A, 229 vs 174, 
kappa = 0.32; reviewer B, 321 vs 314, kappa = 0.46); however, acomparable number of  
segments were s en ifthe vessels of  the foot were excluded. The accuracy (reviewer A, 78% 
vs 68%, p = 0.003; reviewer B, 75% vs 67%, p = 0.003) and sensitivity (reviewer A, 69% vs 
51%, p = 0.001; reviewer B, 68% vs 46%, p = 0.0001) of  CA relative to IOA were superior 
to those of  MRA, although the specificity was comparable (reviewer A, 86% vs 90%, p = 
0.31; reviewer B, 82% vs 87%, p = 0.52). The combination of  MRA and IOA would have 
resulted in the optimal operative plan in 51 of  the 53 cases (96%) and was comparable 
with CA and IOA (53 of  53; 100%; p = 0.50). Substitution of  MRA and IOA for CA and 
IOA could potentiaUy have saved an estimated $60,420. 
Conclusions: The combination of  MRA and IOA provides an accurate, cost-efficient 
strategy for visualization of  the infrageniculate vessels before revascularization 
procedures. (J Vasc Surg 1997;26:415-24.) 
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The clinical utility of magnetic resonance arte- 
riography (MRA) for lower extremity arterial revas- 
cularization remains unresolved. The technique of_ 
fers several practical and theoretical advantages over 
conventional contrast arteriography (CA). Specifi- 
cally, MRA is noninvasive and does not require intra- 
vascular contrast; therefore, the potential complica- 
tions associated with CA as a result of both the 
vascular access and the contrast agent are avoided. 
Furthermore, MRA has been reported to provide 
better visualization of the distal arterial vasculature >4 
and may be more cost-effective, s8 
The widespread application of MRA in patients 
with peripheral vascular occlusive disease is contin- 
gent on adequate visualization of the vasculature 
necessary for successful bypass procedures. However, 
the studies that have examined the adequacy of MRA 
for lower extremity revascularization procedures 
have reported contradictory results. Owen et al. 1 
reported that MRA of the vessels below the adductor 
canal was superior to CA and facilitated revascular- 
ization in 17% of the patients who had been deemed 
unreconstructable by CA. Hoch et al.7 compared 
digital subtraction arteriography (DSA) with MRA 
for patients undergoing infrainguinal revasculariza- 
tion and concluded that MRA alone was sufficient. 
Carpenter et al. ó and Cambria et al.8 have extended 
these observations and have reported series of lower 
extremity revascularization procedures using MRA as 
the sole imaging technique. In contrast, Snidow et 
al. 9 reported that the treatment plan generated by 
the MRA (aorta and runoff vessels) matched that 
from the CA only 41% of the time. Similarly, Quinn 
et al.10 reported that femoral MRA could replace CA 
only 57% of the time. 
Critical analysis of these respective series empha- 
size several imitations in the current application of 
MRA for patients with peripheral vascular occlusive 
disease. First, the accuracy and thus the clinical utility 
of MRA may vary with the anatomic level (infrapop- 
liteal > femoropopliteal > aortoiliac). Second, there 
is a significant leaming curve associated with the 
generation, interpretation, and äpplication of the 
MRA images, a~ and thus the findings from these 
seminal series may be restricted to select centers of 
excellence.~,7,8 Lastly, the MRA technique has been 
validated primarily by comparison with preoperative 
CA, which may be inappropriate in light of the 
lmown limitations of CA to visualize the complete 
distal vasculature in the presence ofmultilevel occlu- 
sive disease? ,1°,i2,13 
This study was designed to determine whether 
infrageniculate MRA provides ufficient visualization 
of the vasculature to allow accurate operative plan- 
ning in paticnts with limb-threatening ischemia. 
PATIENTS AND METHODS 
Study design. Patients with limb-threatening 
ischemia who were undergoing evaluation for infra- 
geniculate arterial revascularization were prospec- 
tively enrolled in the study. All patients underwent 
standard preoperative valuation including both 
time-of-flight MRA of the infrageniculate v ssels and 
CA of the aortoiliac and runoff vessels. Operative 
plans were formulated independently on the basis of 
the CA and the MRA results by the attending sur- 
geon, and the most suitable distal bypass target was 
selected. An amputation was planned if no bypass 
target could be identified. An intraoperative arterio- 
gram (IOA) was performed before revascularization 
or amputation, and the optimal procedure was se- 
lected on the basis of the results of the "gold" stan- 
dard, IOA. 11 The actual procedure performed and 
the optimal bypass target selected were compared 
with those predicted by the preoperative CA and 
MRA. All three imaging studies (CA, MRA, IOA) 
were subsequently reviewed after surgery by two 
independent vascular surgeons in a blinded fash- 
ion. The number of patent vessel segments and the 
number of segments with <50% stenosis were de- 
termined uring the postoperative r view. In addi- 
tion, a post hoc analysis was performed to derer- 
mine whether the site of cannulation for the IOA 
that was selected on the basis of the CA or MRA 
results would have resulted in the optimal opera- 
tive plan. 
Patients. A total of 53 extremities in 49 patients 
were prospectively enrolled in the study from the 
Gainesville Veterans Administration Hospital (49 ex- 
tremities) and the Shands Hospital at the University 
of Florida (four extremities). During the study pe- 
riod, a total of 158 infrageniculate r vascularization 
procedures (study extremities, 53 of 158 [34%]) 
were performed at the two study institutions (VA, 
68; University, 90). Scheduling conflicts between 
the CA and the MRA accounted for the primary 
reason that patients were not enrolled in the study 
because the magnetic resonance scanner was only 
available during the late evening hours. The patient 
demographics reflect he secondary and tertiary clin- 
ical practices at the Veterans Administration and 
University hospitals, respectively (Table I). Notably, 
the majority of the patients were male and diabetic, 
and a significant portion had undergone previous 
ipsilateral lower extremity revascularization proce- 
dures. Rest pain and tissue loss (grade II and III 
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chronic ischemia 14) were the operative indications in 
94% of the cases. 
The distal bypass targets for revascularization 
were selected based on standard principles. Briefly, a 
target was considered suitable if there were no distal 
stenoses that exceeded 50% of the estimated normal 
lumenal diameter. The posterior and anterior tibial 
arteries were considered suitable if their lumen con- 
tinued unobstructed to the foot, whereas the pero- 
neal artelT was deemed suitable if its terminal 
branches collateralized with the foot. The peroneal 
artery was chosen as the distal target before the pedal 
arteries (posterior tibial, dorsalis pedis, medial tarsal, 
lateral tarsal). The pedal arteries were selected when 
no suitable targets were identified above the anlde. 
When more than one vessel was suitable, the most 
proximal site with direct runoff to the foot was se- 
lected; the posterior tibial was sdected before the 
anterior tibial when they were equivocal. The selec- 
tion of the distal target was based solely on the 
quality of the vessels and their runoff, as there was 
sufficient conduit available for revascularization in all 
53 extremities. 
CA. Arteriography was performed by dedicatcd 
interventional radiologists using both cut-film (six of 
53 extremities) and intraarterial digital subtraction 
techniques (47 of 53 extremities). A combination of 
nonionic (iohexol [Omnipaque 350; Winthrop Phar- 
maceuticals, New York], 45 of 53 extremities) and 
carbon dioxide (CO2, eight of 53 extremities) con- 
trast agents were used) s CO 2 was used only in pa- 
tients who had contrast allergy or renal insußciency 
and was frequently supplemented with a small quan- 
tity of iodinatcd contrast o assure adequate visual- 
ization of the distal vasculature. The initial scans at 
the Veterans Administration Hospital were per- 
formed in a Philips Maximus C 1250 (Philips Medi- 
cal Systems, North America Co., Atlanta) angio- 
graphic suite equipped with an ATL 256 matrix 
digital subtraction unit. This equipment was up- 
graded to a Philips DSI 512 matrix DSA unit and 
ultimately to a Philips Integris 3000 with a 1024 
matrix DSA unit. A Toshiba Angiorex ICXO 2050 
(Toshiba America Medical Systems, Tustin, Calif.) 
with a 1024 matrix was also used throughout the 
study at the Shands Hospital at the University of 
Florida. Angiography was performed using 3F and 
4F pigtail, Omni Flush (AngioDynamics, E-Z-EM, 
Qucensbury, N.Y.), or selective catheters with flow 
rates for iodinated contrast ranging from 7 to 12 
ml/sec for 2 to 4 seconds at the level of the aorta and 
4 to 5 ml/sec for 2 to 4 seconds at the external i iac 
artery. CO 2 was injected either manually or with 
Table I. Patient demographics (n = 5 3) 
Age (yr) 68 -4- 10 
Sex (male) 96% 
Medical histroy 




Coronary artery disease (angina, MI, CABG) 42% 
Congestive heart failure 19% 
Renal insufficiency (creatinine >1.5 mg/dl) 29% 
Renal failure 6% 
Surgical history 
Any lower extremity revascularization 5 3% 
Ipsiläteral infrainguinal revascularizafion 21% 
Operative indication 
Claudication 6% 
Rest pain 32% 
Tissue loss 62% 
Noninvasive vascular studies 
Antde-brachial indexes 0.45 -+ 0.15 
Toe pressures (mm Hg) 28 _+ 24 
MI, Myocardial infarction; CABG, coronary artery bypass graft- 
ing. 
powcr injcctor at volumes up to 60 ml for the aorta 
and 30 ml for the external iliac artery. Static DSA 
runs were obtained at overlapping stations covering 
all levels including the foot. When the tibial or pedal 
vessels could not be visualized, the infusion catheter 
was advanccd istally in the arterial tree and contrast 
flow was angmented by elevation of the legs (CO2) 
and by intraarterial nitroglycerine (100 btg). Imaging 
was continued unul either distal runoff vessels had 
opacified and begun to fade, a soff tissue blush had 
appeared, or tiny unnamed vessels had opacified. 
Average iodinated contrast load was approximately 
180 ml and ranged from zero (completely performed 
with CO2) to 280 ml. No significant complications 
(i.e. vascular injury, contrast nephrotoxicity) resulted 
from the conventional rteriograms among the study 
patients. 
MRA. MRA was performed using a 1.5 Tesla 
whole-body scanner (Magnetom Vision; Siemens 
Medical Systems, Iselin, N.J.) and a proprietary knee 
coil. The lower leg from the popliteal artcry down to 
the foot was covered using three study acquisitions. 
Each acquisition took approximately 5 minutes, with 
a total scan Ume of approximately 15 minutes. Time- 
of-flight arteriography was performed using a three- 
dimensional rephase-dephase gradient echo pulse se- 
quence in the sagittal plane. The imaging parameters 
were: repetition time, 50 milliseconds; echo time, 14 
milliseconds; tip angle, 15 degrees; matrix size, 
128 × 256; number of excitations, 1; rectangular 
field-of-view, 125 × 250 mm; 64 mm slab with 48 
partiUons, resulting in a slice thickness of 1.33 mm. 
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An inferior spatial saturation pulse was used for all 
but the foot images to reduce venous signal. The 
data from the three-dimensional acquisition is pro- 
cessed using maximum intensity projection to con- 
struct images of the arteries that rotate at 15 degree 
increments from the sagittal to the coronal plane. No 
specific complications related to the MRA occurred 
among the study patients. 
IOA. The IOA was obtained as the first step of 
the operative procedure. The vessel segment cannu- 
lated (23-gange butterfly) for contrast injection was 
dictated by the vessel segments visualized on the 
preoperative imaging studies. The most proximal site 
that provided visualization of the predicted distal 
bypass target was used for the cannulation, that is, if 
the selected target was the proximal posterior tibial 
artery and the below-knee popliteal segment was 
patent yet stenotic, the below-knee popliteal artery 
was cannulated. When the CA and the MRA pre- 
dicted different argets, the most proximal one was 
selected for the IOA. The procedure was performed 
by manually injecting approximately 12 to 20 ml of 
ionic contrast (Hypaque, Nycomed, New York) 
through the cannulated vessel, and the images were 
obtained using a Phillips BV29 portable X-ray unit. 
Postoperative arteriogram review. The preop- 
erative and intraoperative imaging studies from 46 of 
the 53 limbs (87%) were reviewed independently b
two vascular surgeons (TSH, MRB). Seven cases 
were excluded from the postoperative r view because 
all the necessary films were not available. The review- 
ers werc blinded to the patient's identification, clini- 
cal history, preoperative valuation, and operative 
procedure. The infrageniculate arterial trce was di- 
vided into 14 segments corresponding to the below- 
knee popliteal, tibial-peroneal trunk, anterior tibial 
(proximal, middle, distal), posterior tibial (proximal, 
middle, distal), peroneal (proximal, middle, distal), 
dorsalis pedis, medial tarsal, and lateral tarsal arteries. 
Before the blinded review, all three imaging studies 
(CA, MRA, IOA) from a particular patient were 
evaluated simultaneously, and the arterial tree was 
divided into corresponding segments and marked to 
assure the appropriate comparisons. The vessels con- 
tained within each segment were classified as either 
occluded or patent. The patent segments were fur- 
ther classified as either <50% or ---50% stenotic. In 
addition, the site of cannulation for the IOA was 
selected and recorded. The degree of stenosis was 
determined by visual inspection of the films alone; 
calipers were not used. Lastly, only the projection 
MRA images were used during the blinded review. 
Medical costs. The direct variable costs of CA, 
MRA, and IOA for those patients treated at the 
Shands Hospital at the University of Florida were 
obtained from the Office of Clinical Resource Man- 
agement. Costs for patients treated at the Veterans 
Administration Hospital were defined as the same for 
each procedure. The direct variable costs reflect he 
savings to the institution if an additional resource 
unit is not used and thus are the most appropriate for 
comparison between alternative treatment choices. 
Dircct variable costs differ from total costs in that the 
latrer reflects costs that are incurred on each use as 
weil as local fixed costs associated with the site ofuse, 
such as the angiography suite and its personnel. In 
contrast, hospital charges represent the highest mix 
of local and distant institutional costs shifted among 
sites that typically generate revenues and losses. The 
cost of the additional operating time and its person- 
nel and physician interpretation fees for the imaging 
studies were not included in the cost analysis. 
Statistical analysis. All statistical analyses were 
performed by the Biostatistics Consulting Labora- 
tory at the University ofFlotida College ofMedicine. 
McNemar's test 16 for comparing correlated propor- 
tions was used to compare: the operative plan pre- 
dicted by the CA and MRA relative to the optimal 
plan determined by the IOA; the accuracy, sensitiv- 
ity, and specificity of the CA and the MRA relative to 
the IOA for identifying vessel segments with <50% 
stenoses; and the ability of the CA and MRA to select 
the cannulation site for the IOA. Pairwise agreement 
between the ability of CA and MRA to visualize 
patent vessel segments and between the two review- 
ers for a specific imaging technique was assessed with 
the kappa statistic. 17 The kappa statistic an be inter- 
preted as the percent agreement above that resulting 
from chance alone. Guidelines for the kappa statistic 
have been suggested: K < 0.4, marginal agreement; 
0.4 -< K -< 0.75, moderate agreement; K > 0.75, 
excellent agrecmcnt, is A p value less than 0.05 was 
accepted as significant. The study was approved by 
the Institutional Review Boards of both the Gaines- 
ville Veterans Administration Hospital and the Uni- 
versity of Florida College of Medicine. Informed 
consent was obtained from the study participants. 
RESULTS 
Revascularization procedures were performed in 
44 of 53 lower extremities (83%), and amputation 
was performed in the other nine (17%). Amputations 
were necessary because of the absence of a suitable 
bypass target on the IOA. The bypass procedures 
included femoral-to-below-lmee popliteal in 10 ex- 
tremities (19%), femoral-to-infrapopliteal (tibial per- 
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Table II .  Discrepancies between operative plans based on preoperative and 
intraoperative arteriograms 
Case Distal target-CA Distal target-MRA Actual distal target-IOA 
1 Proximal posterior tibial Below-knee popliteal Below-knee popliteal 
2 Proximal peroneal Mid-posterior tibial Mid-posterior tibial 
3 None* None Disval anterior tibial 
4 Proximal posterior tibiai Below-lmee popiiteal Proximal posterior tibial 
5 Mid-anterior tibial None Mi&anterior tibial 
6 Below-knee popliteal Proximal peroneal Above-lmee popliteal 
7 None None Dorsalis pedis 
8 Mid-posterior tibial Distal posterior tibial Distal posterior ribial 
9 Dorsalis pedis None Dorsalis pedis 
10 Below-knee popliteal Proximal posterior tibial Proximal posterior tibial 
11 Tibioperoneal trunk Tibioperoneal trunk Proximal anterior tibiai 
12 Dorsalis pedis Dorsalis pedis None 
13 Below-knee popliteal Proximal anterior tibial Below-knee popliteal 
14 Proximal anterior tibial Below-knee popliteal Below-knee popliteal 
15 Dorsalis pedis Proximal peroneal None 
16 Lateral tarsal Distal peroneal Lateral tarsal 
17 Proximal anterior tibial Distal anterior tibial Distal anterior tibial 
18 Distal posterior tibial Mid-peroneal Distal posterior tibial 
19 Proximal posterior tibial Tibioperoneal trunk Proximal posterior tibiai 
*No distal bypass target--amputation planned. 
Table II I .  Comparison of CA and MRA for identification fpatent vessel segments (n = 46) 
Reviewer Patent on CA Patent on MRA Patent on CA only Patent on MICA only Kappa 
Reviewer A 229 174 120 65 .323 
Reviewer B 321 314 86 79 .461 
Interobserver ariation; CA vs CA, K = 0.52; MRvs MR, K = 0.49. 
oneal trunk, 2; anterior tibial, 8; posterior tibial, 10; 
peroneal, 3; pedal, 1) in 24 extremities (45%), popli- 
teal-to-infrapopliteal (anterior tibial, 2; posterior tib- 
ial, 6; pedal, 1) in nine extremities (17%), and tibial- 
to-tibial in one extremity (2%). The in-hospital 30- 
day mortality rate was 2% (one of 53), and the overall 
postoperative complication rate was 43% (23 of 53). 
Two bypass grafts failed in the immediate postopera- 
tive period; one was successfully revised (98% initial 
patency rate). Four amputations were performed in 
the postoperative period because of progression of 
the extensive tissue toss; three of the bypass grafts 
were patent at the time of amputation (75% initial 
limb salvage rate). The revascularization procedure 
resulted in an increase in the anlde-brachial index 
greater than 0.2 in 92% of the extremities, with a 
mean increase of 0.49 + 0.23. 
The operative plan prospectively selected by the 
attending surgeon after independent review of the 
CA and the MRA agreed with the optimal plan 
determined by the IOA in 42 of 53 cases (79%) and 
40 of 53 cases (75%), respectively (p = 0.79, McNe- 
mar's test). The discrepancies between the operative 
plans (distal bypass targets) generated by the preop- 
erative imaging studies'and the IOAs are itemized in 
Table II. Analysis of the discrepancies between the 
plans predicted on the CA and those selected from 
the IOA showed that the CA overestimated the de- 
gree of proximal arterial stenosis in three of 11 cases, 
underestimated the degree of distal arterial stenosis 
in four of 11 cases, predicted a suitable bypass target 
when none was present in two of 11 cases, and failed 
to identify asuitable bypass target in two of 11 cases. 
Similarly, analysis of the discrepancies between the 
MRA and the IOA showed that the MICA overesti- 
mated the degree of proximal arterial stenosis in 
three of 13 cases, underestimated the degree of distal 
arterial stenosis in four of 13 cases, predicted a suit- 
able bypass target when none was present in two of 
13 cases, and failed to identify asuitable bypass target 
in four of 13 cases. 
The postoperative r view of the preoperative CA 
and MRA studies revealed that more patent vessel 
segments were identified on the CA (Table III). 
Further analysis on a segment-by-segment basis (for 
example, below&nee popliteal, proximal posterior 
tibial) determined that the arteries in the foot (dor- 
sails pedis, medial tarsal, lateral tarsal) were not well 
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Table IV. Accuracy of CA and MRA for 
detecting vessel segments with <50% 
stenoses (n = 46) 
Reviewer/preoperative 
arteriogram Accuracy Sensitivity Speciflcity 
Reviewer A 
CA 78%* 69%* 86% 
MRA 68% 51% 90% 
Reviewer B 
CA 75%* 68%* 82% 
MRA 67% 46% 87% 
*Significantly different han MRA (p < 0.05, McNemar's test). 
Interobserver variation: CA vs CA, K = 0.61; MR vs MR, K = 
0.76; IOAvs IOA, K = 0.65. 
visualized by MRA. If the vessels in the foot were 
excluded from the analysis, a comparable number of 
patent vessel segments were visualized by CA and 
MRA (reviewer A, I76 vs 170, K = 0.40; reviewer B, 
265 vs 282, K = 0.51). Using the IOA as the stan- 
dard, the accuracy and sensitivity of CA for identify- 
ing vessel segments with <50% stenosis were also 
found to be greater than the MRA (p < 0.05, Mc- 
Nemar's test) during the postoperative r view (Table 
IV). The specificities, however, were comparable. 
Post hoc analysis revealed that the cannulation 
site for IOA (the most proximal patent vessel seg- 
ment in continuity with the predicted bypass target) 
selected using the preoperative CA and MRA would 
have resulted in the optimal operative plan in 53 of 
53 cases (100%) and 51 of 53 cases (96%), respec- 
tively (p = 0.50, McNemar's test). The combination 
of MR/ IOA would have failed to visualize the opti- 
mal bypass target in the two cases because patent 
vessels were erroneously found to be occluded on the 
MRA. Specifically, a femoral-peroneal bypass proce- 
dure would have been performed based on the 
MRA/ IOA in the first case rather than the optimal 
femoral-below-lmee popliteal bypass becanse the 
MRA failed to identify a minimally diseased below- 
knee popliteal artery. In the second case, an amputa- 
tion would have been performed based on the 
MRA/ IOA rather than a femoral-anterior tibial by- 
pass procedure because no suitable vessels were iden- 
tified for the IOA by the MRA. 
The direct variable cost for the arteriographic 
imaging studies are shown in Table V. The total 
estimated irect variable cost for a outpatient CA 
encompassing the aorta and run-off vessels and an 
IOA in the 53 study patients is $71,868. The esti- 
mated direct variable cost for an MRA and an IOA 
for the study patients is contingent on the extent of 
the arterial tree imaged: MR aortogram and runoff 
Table V. Direct variable costs for the 
arterial imaging techniques 
Procedure Cost ($)/study 
CA and runoff (outpatient) 1310 
MRA and runoff 670 
MRA--infrainguinal, unilateral 335 
MRA--infrageniculate, unilateral 170 
IOA 46 
vessels/IOA, $37,948; MR infrainguinal arterio- 
gram/IOA, $20,193; MR infrageniculate arterio- 
gram/IOA, $11,448. Substitution of the CA with 
MRA would result in a significant cost savings. 
DISCUSSION 
The smdy was designed to determine whcther 
infrageniculate MRA provides ufficient visualization 
to allow accurate planning for revascularization pro- 
cedures. Interpretation of the results is confounded 
by the inaccuracy of both the CA and the MRA 
relative to IOA for selection of the optimal operative 
plan and distal bypass target. The most appropriate 
interpretation of our results is that the combination 
of MRA/ IOA is comparable with the combination 
of CA/ IOA and is therefore a suitable replacement. 
There were two discrepancies between the operative 
plans based on the MRA/ IOA and the CA/IOA. 
One would not have resulted in any clinical signifi- 
cance, as the bypass procedure would have been 
performed to the next distal anatomie level. An am- 
putation, however, would potentially have been per- 
formed unnecessarily in the other case because no 
suitable site for cannulation for the IOA was idcnti- 
fied on the MRA. In actuality, this may have been 
prevented because it is our practicc in this scenario t
explore all potential bypass targets and obtaln IOAs. 
The use of MRA/ IOA together is a variation of the 
concept proposcd by Baum et al.19 ofusing the MRA 
as the primary imaging technique with supplementa- 
tion by CA as necessary. It should be emphasized, 
howcvcr, that our conclusions are restricted to the 
infrageniculate level only. Further investigation will 
be necessary to determine whether MRA is suffi- 
cicntly accurate to replace CA at morc proximal 
levels because previous reports are contradictory. 
Carpenter ct al.20 have proposed that MRA is com- 
parable with CA for imaging the aorta, iliac and 
femoral vessels, whereas Snidow et al.9 reported that 
MRA (aorta and runoff) was infcrior to CA for plan- 
ning lower extremity revascularization a d that all 
the treatment failures were a result of inadequate 
visualization of the iliac vessels. Alternatively, signif- 
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icant proximal lower extremity occlusive disease 
could be investigated using arterial duplex scanning 
and hemodynamic measurements. 
The overall visualization of the distal vasculature 
was not found to be as good on the MRA as the CA. 
Our findings contradict multiple reports that docu- 
ment better visualization of patent vessel segments 
on MI~A_. 1-4 Admittediy, the clinical relevance of the 
total number of patent vessel segments i  unclear. 
Furthermore, the sensitivity of MRA was not as good 
in our study as reported by Baum et al. 11 from a 
multicenter study ofinfrageniculate MRA that used a 
similar experimental design. The discrepancies be- 
tween out study and these other reports are likely 
multifactorial. First, the overall image quality of the 
CAs were very good. Concerted efforts were made by 
the interventional radiologists to visualize all of the 
distal vasculature and included liberal use of intraar- 
terial vasodilators, positional changes, selective vessel 
cannulation, and digital subtraction imaging. 21 Sec- 
ond, the vessels in the foot were not imaged very well 
by the MRA. Similar reports that examined the role 
of MRA for the infrageniculate v ssels have excluded 
the vessels of the foot. 1,4 However, Unger et al.22 
and McDermott et al. 23 specifically examined the 
role of MRA for the vessels of the foot and ankle in 
patients with occlusive disease and concluded that 
MRA was superior to CA. Third, the films were 
reviewed after surgery by independent vascuhr sur- 
geons rather than a panel of reviewers. Lastly, only 
the projection MRA images were reviewed, and Mc- 
Cauley et al? attributed part of the increased visual- 
ization of the distal vasculature to use of the axial 
(cross-sectional) images. 
The leaming curve has been frequently sited to 
explain the differences between the quality and reli- 
ability of the MRAs? ,n Clearly, there is a learning 
component to the application of the technology and 
the images differ from the more familiar CA. Baum et 
al}l reported that there was variability among the 
accuracy of the images across time, institution, and 
reviewer. The requisite learning curve for MRA is 
comparable with that for vascular ultrasound. Valida- 
tion of the technique both by individual surgeons 
and institutions i optimal before its clinical applica- 
tion and is comparable with the validation of carotid 
duplex with cerebral arteriography before its use as 
the sole imaging technique for carotid endarterec- 
tomy. 
Replacement of the CA with a combination of 
MRA and IOA would result in a significant cost 
savings to the institution. The reported cost effi- 
ciency of MRA varies significantly in the literature, 
primarily a result of the assessment of the costs, s-8 
The direct variable costs to the institution were used 
in the current study because they reflect he cost to 
the institution if an additional resource unit is used. 
This method of accounting is not universal, but it is 
the most appropriate to evaluate the choice between 
alternative resources. The cost of the operating time 
and associated personnel were not factored into the 
direct variable cost of the IOA. Admittedly, the IOA 
adds approximately 13 minutes to the operative pro- 
cedure in our practice, 24 but this is relatively modest 
in light of the overall duration of the operative pro- 
cedure. In addition, the results of the IOA favorably 
impacted the selection of the optimal distal target, 
and this impact may improve long-term patency. 
Furthermore, our evaluation of the cost-efficiency of
MRA was limited to the cost of the imaging tech- 
niques alone. Appropriate assessment of the cost ef- 
fectiveness ofmedical practices requires analysis of all 
the associated costs and benefits. Interestingly, Yin et 
al. s evaluated the cost effectiveness ofMRA for limb- 
threatening ischemia and concluded that it was a 
cost-effective alternative to CA if acceptable sensitiv- 
ity and specificity thresholds were achieved. 
This study indirectly defines the utility of IOA 
during lower extremity revascularization procedures 
in patients with limb-threatening ischemia. The IOA 
served as the "gold" standard 11for evaluating both 
the CAs and the MRAs, but the findings resulted in a 
change in the operative plan. generated from the 
, preoperative imaging studies :in approximately 25% 
of the cases. Admittedly, the impact of the IOA was 
modest in most cases and resulted in repositioning 
the distal bypass target within the vessel identified by 
the preoperative imaging studies. The significance of 
these changes on the long-term graft patency and 
limb-salvage rates is unknown, but selection of the 
optimal distal target is consistent with the standard 
surgical principles. We have used IOA liberally in our 
practice to supplement the CA in this setting and 
have justified its use by our blas that preoperative CA 
orten falls to completely visualize the distal vascula- 
ture in the presence of multilevel occlusive disease. 
We have recently validated our approach in a pro- 
spective study of 114 distal revascularization proce- 
dures and found that IOA altered the operative plan 
24% of the time. 23 Similar studies have reported that 
preoperative CA failed to image suitable bypass tar- 
gets in as many as 70% of the cases. 2~28 
Although the current analysis focused on the po- 
tential cost savings associated with MRA, there are 
other compelling reasons to substitute MRA for CA. 
Primarily, MRA is noninvasive and does not require 
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intravenous contrast. The overall complication rate 
for CA ranges from 2% to 10%, 29.32 with a major 
complication rate of 0.8%. 29 MRA is not a panacea, 
however, as there are several inherent disadvantages. 
MRA is contraindicated in the subset ofpatients who 
have cardiac pacemakers, aneurysm clips, and in- 
traocular metal fragments and may be contraindi- 
cated in patients who have intravascular stents. The 
applicability of MRA is limited in the critical care 
setting. MRA provides only anatomic information 
and does not readily lend itselfto intervention or the 
assessment ofhemodynamic parameters. In addition, 
the image acquisition times are longer, and the qual- 
ity of the images may be inferior in specific anatomic 
locations. Many of these limitations and specifically 
the last two, however, should become less problem- 
atic as the technology improves. 
Two addifional features of the study merit further 
comment. First, there was a moderate amount of 
variability in the techniques (cut film, DSA), equip- 
ment, and contrast agents (iodinated, CO2) used for 
the CAs. The ner impact of this variabilitT, however, 
on the overall quality of the CAs was likely minimal. 
The visualization of  the distal vasculature by the CA 
was not considered adequate by the interventional 
radiologists until a specific endpoint was achieved 
(i.e., distal vessel opacification, soff tissue blush, 
opacification of unnamed vessels). These endpoints 
were consistent throughout the study and were inde- 
pendent of  the imaging variables. In addition, subset 
analysis of the CAs by the equipment and the con- 
trast agent showed no difference in the ability to 
predict he optimal bypass target. Second, friere was 
a moderate amount of interobserver variation be- 
tween the two vascular surgeons during the postop- 
erative reviews of  the imaging studies. The explana- 
tion for these differences is not obvious but may 
result from differences in experience and bias, partic- 
ularly with regard to the suitability of  a distal bypass 
target (vessel segments with <50% stenosis). As 
noted above, the interobserver variation could likely 
have been decreased had the films been read by a 
panel ofradiologists, bnt the clinical relevance would 
be less. 
CONCLUSION 
Infrageniculate MRA predicted the opumal oper- 
ative plan approximately 75% of the time in patients 
with limb-threatening ischemia nd was comparable 
with CA. CA visualized more patent vessel segments 
below the knee than the MRA, but a comparable 
number of patent segments were visualized if the 
vessels in the foot were excluded. The overall accu- 
racy and sensitivity of CA were better for visualizing 
vessel segments with < 50% stenoses, but the specific- 
ity was comparable. The combination of MRA and 
IOA would have resulted in the optimal operafive 
plan in 96% of the cases and provides an accurate, 
cost-efficient strategy for visualization of  the infra- 
geniculate vessels before rcvascularization proce- 
dures. 
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DISCUSSION 
Dr. Richard P. Cambria (Boston, Mass.). The au- 
thors have added to the growing yet still modest literature 
on the utility of MRA used by surgeons to formulate plans 
for infrainguinal bypass procedures. Our own perspective 
in this regard dates to 1990, and our recently completed 
prospective study of nearly 100 patients who underwent 
both studies appears in the February issue of the Journal of 
Vascular Surgery [1997;25:380-9]. Our data echo many of 
the themes highlighted by the group from Gainesville this 
morning. Specifically and firsfly, the alleged superiority of 
MRA in demonstrating so-called angiographically occuh 
run-offvessels, soprominently noted in a series ofpublica- 
tions from the Pennsylvania group, could not be confirmed 
either in our data nor that we just heard. In fact, the 
authors noted as many as 20% more patent run-offvessels 
detected with CA when the foot vessels were included. 
However, there was significant interobserver variability 
among the two surgeon retrospective r viewers. Secondly, 
the qualitative assessment of potential tibial bypass recipi- 
ent vessels, in this study those with <50% stenosis, was 
suf~erior with arteriography asopposed to MRA. This is 
also consistent with ohr own data and that from the multi- 
center study published 18 months ago in JAMA. Finally, 
specific treatment plans formulated after MRA and those 
formulated after arteriography agreed in some 75% oftheir 
cases, with the corresponding fi ures in our study and the 
multicenter study being a bit higher--in the 85% range. 
It seems fair to conclude that after acquisition of suffi- 
cient correlative xperience with angiography and MRA 
that leg revascularization with MRA alone will not only be 
feasible but possibly desirable from the standpoint of pa- 
tient safety and cost considerations i  certain patients. The 
task, of course, is to find in which patients this strategy is 
best applied, with the important and obvious provision 
that MRA will result in cost savings only when used in 
place of, and not in addition to, CA. In our practice, MRA 
is frequently used as the sole preoperative imaging study in 
those patients deemed to be at undo risk for arteriography- 
related complications, for example, those with renal failure. 
Although I agree with the authors' emphasis on MRA 
development, I disagree with the strategy that they advo- 
cate and their apparent reliance on prebypass IOA. In the 
manuscript, they cite the same four reports, all more than a 
decade old, that appear to verify the necessity for prebypass 
arteriography, and indeed the proponents of MRA cite 
these same reports to emphasize the alleged shortcomings 
of preoperative diagnostic arteriography. The authors re- 
ported a 25% rate ofchange in plans with IOA, irrespective 
ofwhether the initial study was an angiogram or an MRA. 
I believe that the use of a preoperative imaging smdy to 
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merely decide on a cannulation site for prebypass IOA is a 
giant step backwards. I much prefer the detailed studies 
with magnified lateral foot views that our vascular radiolo- 
gists provide for us to anything I can obtain in the operat- 
ing room with a single static nonsubtracted view. Their 
manuscript does detail the change in arteriography equip- 
ment and technique at their institution over the period of 
the study, and I am curious about their use of CO 2 arte- 
riography in the leg. Although this technique can save on 
contrast load, resolution can suffer. Would the authors 
comment on this point? In our opinion, prebypass arte- 
riography or the alleged bettet demonstration of ran-oft 
vessels with MRA is explained with two words: inadequate 
arteriography. 
I have several questions about the study design and 
methods. The authors use the unusual technique of study- 
ing the proximal leg and inflow with arteriography and the 
infrageniculate arteries with MRA. Why was this strategy 
selected? Gadolinium-enhanced MRA is now widely used 
to study more proximal arteries. Why was a knee coil, as 
opposed to an extremity or head coil, used? It requires 
three separate acquisitions to study the lower leg. This will 
create inevitable problems in reconstructing the maximum 
intensity projection arteriogram. What was your institu- 
tional experience with MRA before the advent of this 
study, or where does this study fit on your own learning 
curve with MRA? Next, comparative anatomie data were 
accumulated retrospectively by two surgeon reviewers. 
Why was this data not collected prospectively, and why 
were the vascular adiologist's interpretations ot consid- 
ered in this analysis? 
I enjoyed this presentation and am pleased that more 
institutions are reporilng experience to add balance to the 
literature that has been skewed by a preponderance of
reports from a single insiltution. 
Dr. Thomas S. Huber.  I would like to thank Dr. 
Cambria, and we recognize his contilbution to the fiel& I 
will attempt an item-by-item response to his questions. 
The first one, in regard to the use of CO2, itis a technique 
that we have reported from our institution. We have been 
very satisfied with the quality of the images and have found 
it to be comparable with standard contrast arteriography. 
The added advantage is that it is nonnephrotoxic. We used 
a knee coil because that was what was available at the ilme 
of the study. We are in the process of imaging the more 
proximal arterial trees, specifically, the femoral-popliteal 
and the aortoiliac segment. Before this study, we had fairly 
limited experience using MRA in the peripheral vasculature 
but extensive xperience in the carotid circulation. Our 
study was designed solely to look at the clinical utility of 
MRA and the clinical utility from a vascular surgeon's 
standpoint. It was designed to answer the question of 
whether MRA could be used to pick the bypass target or 
the most appropriate operation. We went back and re- 
viewed the films after surgery, in a sense to validate our 
observailons. Our thought was that we wantcd to validate 
our observations from a vascular surgeon's tandpoint 
rather than from a radiology standpoint. 
Dr. Daniel F. Fisher, Jr. (Chattanooga, Tenn.). I was 
particularly interested in the 9% ofpatients who ended up 
undergoing amputation despite a bypass graft. Several 
years ago in Phoenix, we presented a seiles of patients in 
which this was also the case. Many of these patients were 
dialysis-dependent pa ients. Could you make a comment 
about the 9% of patients that had the amputations? Sec- 
ondly, it has always been my particular blas that trying to 
perform a below-knee amputation i a patient with a fresh 
occlusion of a distal bypass frequently results in an above- 
lcnee amputation, Whereas if the bypass procedure was not 
performed, a below-knee amputation would probably heal. 
Did you find that any of these patients had to be converted 
from what would have been a successfifl below-knee ampu- 
tation to an above-knee amputation? 
Dr. Huber.  In answer to your two questions, a third of 
the patients had renal insufficiency and two of the patients 
had end-stage renal failure. We did not analyze the data by 
whether the patients had renal failure or renal insufficiency. 
One of the patients who underwent an amputation was one 
of the two patients who had renal failure. We have taken a 
fairly aggressive approach to performing distal bypass pro- 
cedures in patients with renal failure and renal insufficiency. 
In regard to whether early graft failure compromised the 
amputation level, it did not appear to. 
Dr. Stanley O. Snyder, Jr. (Nashville, Tenn.). I may 
have missed something in your presentation, but did you 
say that there were t-wo patients who had outflow vessels 
that showed up on CA that did not show up on IOA? Ifso, 
how do you think that happened, and how much contrast 
do you use for your intraoperailve angiogram? 
Dr. Huber.  The vessels howed up on the IOA, but 
they were not deemed suitable as distal bypass targets. Our 
IOA technique isto cut down on the most proximal patent 
vessel in continuity with the distal bypass target selected 
and inject approximately 15 ml ofionic contrast. 
Dr. Mitchell Goldman (Knoxville, Tenn.). I enjoyed 
your paper. I just have a silly question. In Tennessee, we 
have had trouble getting the folks to pay for the peripheral 
MRA. How did you do that? 
Dr. Huber.  ~The MRAs were performed as part of a 
study funded by our institution to look at alternative cost- 
efficient medical practices. 
Dr. Goldman. Will they, in Florida, pay for it, though? 
Dr. Huber.  I think that if there is an appropriate 
clinical indication the third-party payers will pay. 
